Evidence-based treatments for human health
We are building a pipeline of evidence-based health products, through in-house development and in-licensing / partnership opportunities.
Research
Anti-Obesity
Anatara’s Anti-Obesity Program
Obesity is a medical condition of such prevalence that it is described as a new pandemic. With associated significant comorbidities and health risk factors, Anatara Lifesciences is excited to announce that it is commencing a new anti-obesity project.
The project aims to develop an oral medication to assist weight reduction and sustain weight control in conjunction with other contemporary treatments and approaches.
Research
Phase I/II IBS Clinical Trial
Irritable Bowel Syndrome (IBS) trial
Anatara Lifesciences has now concluded its human clinical trial on Irritable Bowel Syndrome (IBS).
As seen on
about
Meet Anatara
INNOVATIVE SOLUTIONS FOR HUMAN HEALTH:
ANATARA LIFESCIENCES (ASX:ANR)
Anatara Lifesciences (ASX:ANR) specialises in creating evidence-based innovative products to address unmet needs in human health. Our focus is on building a pipeline of health products through development of our own proprietary technology as well as strategic partnerships. Our core commitment is to deliver tangible benefits to patients and create significant value for our shareholders.
about IBS
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is the most commonly diagnosed gastrointestinal condition and a significant cost burden on health care.
11
%
Products
& Pipelines
Developing products
for gastrointestinal health
Anatara Lifesciences is developing and commercialising innovative, evidence-based health products to address significant unmet need, with a particular focus on conditions that involve the complexity of the gastrointestinal tract
